This is a non-core endpoint: only basic statistics are computed.
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
C3_BONE_CARTILAGE_NAS
bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
194 |
4. Check minimum number of eventsNone |
194 |
5. Include endpointsNone |
194 |
6. Filter based on genotype QC (FinnGen only) |
189 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of bone and articular cartilage of other and unspecified sites
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of bone and articular cartilage
- Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo
- Solid cancers, helper endpoint
- Malignant neoplasm
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 189 | 89 | 100 |
| Unadjusted period prevalence (%) | 0.04 | 0.03 | 0.05 |
| Median age at first event (years) | 60.95 | 59.07 | 62.63 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 194
- Matched controls
- 1940
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
119.0
142.8
74
10
JN4BD
NOMESCO Finland
Extensive body CT
21.2
76.2
65
45
XX3DW
NOMESCO Finland
Time consuming IT work
21.8
73.3
61
40
H02AB02
ATC
dexamethasone; systemic
165.4
73.0
73
7
A04AA01
ATC
ondansetron; systemic, rectal
31.6
69.5
48
20
JN4AD
NOMESCO Finland
Body CT examination
18.9
69.0
62
47
XW000
NOMESCO Finland
Bone marrow biopsy
29.2
66.2
47
21
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
172.4
59.8
60
5
130
Kela drug reimbursment
Malignant tumour
+∞
54.8
50
*
N02AA05
ATC
oxycodone; systemic
9.6
54.1
89
157
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
46.8
43
*
A03FA01
ATC
metoclopramide; systemic, rectal
9.0
46.8
76
130
L03AA02
ATC
filgrastim; parenteral
526.8
44.0
42
*
Z51.5
ICD-10 Finland
Palliative care
18.8
43.7
37
24
WZC00
NOMESCO Finland
Treatment plan or consultation
7.0
41.7
116
338
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
40.0
37
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
40.0
37
*
C90.0
ICD-10 Finland
Multiple myeloma
+∞
37.7
35
*
A04AA02
ATC
granisetron; systemic, transdermal
399.1
34.0
33
*
WF002
NOMESCO Finland
Radical radiotherapy
141.4
33.9
35
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
369.2
31.8
31
*
L03AA13
ATC
pegfilgrastim; parenteral
369.2
31.8
31
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
27.8
26
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
43.8
27.2
33
9
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
26.7
25
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
26.4
35
45
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
155.9
26.3
27
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
25.6
24
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
10.1
25.2
31
36
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.6
23.7
33
45
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
23.4
22
*
WX402
NOMESCO Finland
General anaesthesia
4.9
23.1
67
188
NE1AA
NOMESCO Finland
Pelvis X-ray examination
6.9
22.5
39
68
WX408
NOMESCO Finland
General anesthesy, balanced
4.4
22.3
81
270
B01AB05
ATC
enoxaparin; parenteral
4.2
22.0
95
358
N03AX16
ATC
[U] pregabalin
4.3
21.1
82
285
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
25.9
21.1
29
13
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.2
20.6
128
615
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
20.1
19
*
153
Kela drug reimbursment
Lenalidomid
+∞
20.1
19
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.6
20.1
44
96
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.5
19.8
63
188
WZC30
NOMESCO Finland
Teaching
5.0
19.3
50
126
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
19.1
18
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
19.1
18
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
19.1
18
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
19.1
18
*
ZX120
NOMESCO Finland
Intravenous
6.4
18.1
33
60
JN4CD
NOMESCO Finland
Very extensive body CT
28.8
17.4
23
9
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
17.2
17.3
27
18
L04AX04
ATC
lenalidomide; oral
+∞
16.9
16
*
329
Kela drug reimbursment
Lenalidomide
+∞
16.9
16
*
R4110
NOMESCO Finland
Physiotherapy
3.6
16.7
83
333
B01AB10
ATC
tinzaparin; parenteral
6.0
15.9
31
60
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
15.8
15
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
15.8
15
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
15.8
15
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
15.8
15
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.9
14.9
29
56
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
14.8
14
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
14.8
14
*
WW500
NOMESCO Finland
Blood transfusion
15.0
14.7
24
18
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.0
14.7
24
18
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
13.7
13
*
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
13.7
13
*
C41.4
ICD-10 Finland
Malignant neoplasm: Pelvic bones, sacrum and coccyx
+∞
13.7
13
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
150.1
13.6
14
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.4
13.5
38
101
GD1AD
NOMESCO Finland
Thorax CT examination
6.1
13.5
25
46
TPH07
NOMESCO Finland
Cathetrisation of artery
4.3
13.0
38
104
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.9
12.6
24
45
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
12.6
12
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
12.6
12
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
12.6
12
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
12.6
12
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
12.6
12
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
138.6
12.6
13
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
40.4
12.4
15
*
J05AB01
ATC
aciclovir; systemic
3.2
11.8
60
237
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
11.6
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.6
11
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
11.6
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.6
11
*
M05BX04
ATC
denosumab; parenteral
6.1
11.4
21
38
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
37.5
11.4
14
*
R50.9
ICD-10 Finland
Fever, unspecified
3.5
11.0
45
155
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
30.0
10.9
14
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
15.4
10.7
17
12
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
15.4
10.7
17
12
D70.82
ICD-10 Finland
Drug-induced neutropenia
116.0
10.5
11
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
10.5
10
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
10.5
10
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
10.5
10
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
10.5
10
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
10.5
10
*
115
Kela drug reimbursment
Breast cancer
+∞
10.5
10
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
10.5
10
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
10.5
10
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.8
10.4
25
58
ZXE30
NOMESCO Finland
More than five and less than seven hours
10.4
10.0
19
20
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.6
10.0
25
60
JN6AD
NOMESCO Finland
CT of torso and neck
27.7
9.9
13
5
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.6
9.9
21
27
TPX10
NOMESCO Finland
Implantation of vascular injection port
12.3
9.8
17
15
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
58.0
9.7
11
*
N02BF02
ATC
pregabalin; oral
4.9
9.6
22
49
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
9.4
9.5
19
22
WX306
NOMESCO Finland
Lumbar epidural anesthesy
5.3
9.5
20
41
A06AH03
ATC
naloxegol; oral
104.9
9.5
10
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
+∞
9.4
9
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
9.4
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
9680/3-C41.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of vertebral column
+∞
9.4
9
*
HA1AA
NOMESCO Finland
X-ray mammography
9.8
9.3
18
20
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
12.3
9.3
16
14
ZXE20
NOMESCO Finland
More than three and less than five hours
3.3
8.7
38
135
ZXE10
NOMESCO Finland
More than one and less than three hours
2.5
8.5
82
443
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
8.4
8
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
8.4
8
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
8.4
8
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.2
8.1
36
129
AA1AA
NOMESCO Finland
Head X-ray examination
23.2
8.1
11
5
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
23.2
8.1
11
5
J01MA12
ATC
levofloxacin; systemic
2.9
7.8
44
181
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
46.9
7.8
9
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.2
7.8
22
58
H02AB09
ATC
hydrocortisone; systemic
10.7
7.7
14
14
M04AA01
ATC
allopurinol; systemic
2.9
7.6
40
158
B01AB04
ATC
dalteparin; parenteral
7.0
7.6
18
28
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.4
7.5
73
391
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
11.5
7.4
13
12
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.8
7.3
17
38
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
7.3
7
*
C41.20
ICD-10 Finland
Malignant tumor of the spine without histology
+∞
7.3
7
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
7.3
7
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
+∞
7.3
7
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
7.3
7
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
7.3
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.3
7
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
7.3
7
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
7.3
7
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
7.3
7
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
C41.2
ICD-10 Finland
Malignant neoplasm: Vertebral column
+∞
7.3
7
*
WW409
NOMESCO Finland
Other aferesis
+∞
7.3
7
*
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
16.5
7.3
11
7
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
7.2
46
201
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
6.1
7.0
18
32
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.6
6.9
46
206
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
41.5
6.8
8
*
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
6.7
93
573
ZXE40
NOMESCO Finland
More than seven and less than nine hours
12.9
6.7
11
9
A02BC02
ATC
pantoprazole; systemic
2.3
6.7
139
1007
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
6.5
43
191
ZXD05
NOMESCO Finland
Urgent procedure
2.3
6.5
70
388
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
7.5
6.3
14
20
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
18.8
6.3
9
5
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
C41.0
ICD-10 Finland
Malignant neoplasm: Bones of skull and face
+∞
6.3
6
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
6.3
6
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
6.3
6
*
9731/3-C41.9
ICD-O-3
Plasmacytoma, NOS, of bone, NOS
+∞
6.3
6
*
WW402
NOMESCO Finland
Leucoferesis
+∞
6.3
6
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
6.3
6
*
C41.06
ICD-10 Finland
Chondrosarcoma of the skull or facial bones except maxilla
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
6.3
6
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
6.3
6
*
C41.09
ICD-10 Finland
Malignant tumor of the skull or facial bones other or unspecified histology
+∞
6.3
6
*
C41.29
ICD-10 Finland
Malignant tumor of the spine other or unspecified histology
+∞
6.3
6
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
6.3
6
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
9731/3-C41.4
ICD-O-3
Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
6.3
6
*
L02BG04
ATC
letrozole; oral
27.7
6.3
8
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
6.2
29
107
N02BE01
ATC
paracetamol; systemic, rectal
3.5
6.0
178
1475
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
88
133
11.28
61.59
7.2
3.3
225.26
239.07
u/l
0.64
88
126
55
44
17.05
58.93
11.5
1.3
37.19
31.29
mg/l
0.11
48
36
55
44
17.05
58.93
11.6
1.3
35.66
44.91
mg/l
0.51
48
36
75
186
5.94
30.74
6.7
6.4
1.04
1.08
mmol/l
0.52
75
170
77
208
5.48
28.38
5.8
3.4
0.82
0.83
mmol/l
0.40
77
195
155
763
6.13
26.49
14.2
3.8
9.79
11.73
umol/l
2.22
149
718
92
329
4.42
23.13
4.1
2.0
—
—
—
0
0
157
843
5.52
22.37
23.8
6.3
4.21
4.19
e9/l
0.01
144
739
136
656
4.59
22.37
4.4
2.3
—
—
—
0
0
136
667
4.48
21.58
14.1
5.6
1.20
1.21
mmol/l
1.05
131
601
143
736
4.59
21.00
17.6
5.6
1.20
1.21
mmol/l
1.55
126
644
40
78
6.20
20.59
5.8
1.7
4.97
2.68
ug/l
0.78
31
58
57
176
4.17
16.83
10.3
7.3
1.55
1.60
mmol/l
0.03
45
144
99
453
3.42
16.01
9.5
2.0
2.35
2.35
mmol/l
0.06
93
387
24
36
7.47
15.69
1.8
1.2
—
—
—
0
0
29
59
5.60
14.08
8.2
1.2
1.21
0.32
g/l
0.70
24
51
64
240
3.49
13.96
2.1
1.6
—
—
—
0
0
31
68
5.24
13.86
8.0
1.2
—
—
—
0
0
90
419
3.14
13.66
4.1
2.4
5889.89
9285.26
umol/l
0.30
85
362
147
909
3.55
13.55
9.7
4.4
6.58
6.75
mmol/l
0.59
142
845
127
729
3.15
13.13
12.5
14.5
1.24
1.34
inr
0.65
37
193
34
87
4.53
12.62
13.3
7.5
25.27
25.13
mmol/l
0.09
34
87
100
538
2.77
11.06
4.1
3.3
—
—
—
0
0
84
421
2.76
10.56
3.8
3.1
0.99
0.29
e6/l
0.42
66
307
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
21
44
5.23
9.79
2.2
3.6
0.35
0.38
u/ml
0.15
12
22
31
90
3.91
9.66
15.1
10.0
0.67
0.68
%
0.05
31
90
31
90
3.91
9.66
14.9
10.1
1.35
1.50
%
0.47
31
90
16
14
12.33
9.25
2.7
1.9
—
—
—
0
0
43
168
3.00
8.39
2.1
1.6
—
—
—
0
0
13
9
15.36
8.33
1.8
2.9
—
—
—
0
0
19
29
7.14
8.12
1.8
1.5
—
—
—
0
0
31
104
3.36
7.76
1.9
2.0
0.19
0.20
g/l
0.35
31
93
42
169
2.90
7.74
2.1
1.6
—
—
—
0
0
36
134
3.07
7.61
4.7
3.2
—
—
—
0
0
17
25
7.34
7.48
1.6
1.4
—
—
—
0
0
7
0
+∞
7.33
2.1
0.0
18.57
—
u/ml
—
7
0
15
19
8.46
7.25
1.7
1.2
—
—
—
0
0
43
182
2.75
7.19
9.9
5.6
104.16
104.11
mmol/l
0.02
43
182
13
13
10.62
7.15
1.2
1.2
—
—
—
0
0
26
87
3.30
6.52
2.0
1.5
—
—
—
0
0
27
93
3.21
6.46
2.7
1.4
—
—
—
0
0
16
27
6.36
6.46
1.6
1.3
—
—
—
0
0
18
36
5.40
6.37
1.9
2.2
23.22
15.46
u/ml
0.32
18
26
9
5
18.77
6.32
2.7
2.4
—
—
—
0
0
30
112
2.99
6.27
2.7
2.0
73.53
66.39
ml/min/173m2
0.45
17
36
53
268
2.35
6.04
3.2
2.7
0.78
0.91
e6/l
0.20
31
152
13
18
7.65
6.03
4.6
4.9
9.67
11.37
mg/l
0.58
13
18
66
370
2.19
5.87
2.1
2.0
2.57
2.91
mg/l
0.75
58
320
49
249
2.29
5.48
4.1
2.9
3.68
2.16
e6/l
0.43
29
135
17
48
3.79
5.46
9.4
1.2
0.00
0.00
g/l
-0.00
17
43
5
0
+∞
5.23
4.6
0.0
—
—
—
0
0
5
0
+∞
5.23
1.6
0.0
—
—
—
0
0
11
16
7.22
5.03
1.5
1.2
—
—
—
0
0
183
1586
3.71
4.84
37.1
11.9
29.43
24.13
mg/l
1.41
169
1204
40
198
2.29
4.72
3.6
2.6
2.18
2.35
g/l
0.97
40
181
26
105
2.70
4.70
2.7
1.4
—
—
—
0
0
56
318
2.07
4.69
3.8
1.7
0.93
0.90
mg/l
0.10
45
243
94
644
1.89
4.54
4.1
3.8
30.02
44.71
ng/l
0.97
78
455
11
19
6.07
4.51
1.5
1.2
—
—
—
0
0
11
19
6.07
4.51
1.5
1.2
—
—
—
0
0
9
12
7.80
4.40
1.0
1.0
—
—
—
0
0
9
12
7.80
4.40
1.7
1.3
—
—
—
0
0
8
9
9.21
4.32
2.4
1.3
3.26
4.57
nmol/l
—
8
9
11
22
5.23
4.07
7.4
4.6
60.45
59.32
%
0.09
11
22
75
494
1.84
3.98
4.6
3.3
1003.49
1278.04
ng/l
0.40
70
416
10
19
5.49
3.88
1.6
1.2
—
—
—
0
0
172
1483
2.41
3.84
32.8
10.9
81.89
79.69
ml/min/173m2
0.56
148
1176
14
40
3.69
3.69
4.2
2.8
90.71
95.57
%
0.32
14
40
11
25
4.60
3.68
1.5
1.2
—
—
—
0
0
16
58
2.92
3.51
2.4
1.6
—
—
—
0
0
10
22
4.73
3.48
6.4
3.8
3.59
4.72
e9/l
—
10
22
9
18
5.19
3.41
1.7
1.2
—
—
—
0
0
9
19
4.91
3.28
1.6
1.1
—
—
—
0
0
15
55
2.87
3.23
2.1
1.5
—
—
—
0
0
8
15
5.51
3.22
1.3
1.1
—
—
—
0
0
11
30
3.82
3.14
1.8
1.1
—
—
—
0
0
11
30
3.82
3.14
1.8
1.1
—
—
—
0
0
28
142
2.14
3.09
3.8
1.8
382.61
361.83
nmol/l
0.25
28
131
7
12
6.00
3.05
1.6
1.1
—
—
—
0
0
7
12
6.00
3.05
2.0
1.9
—
—
—
0
0
7
12
6.00
3.05
1.6
1.1
—
—
—
0
0
7
12
6.00
3.05
1.6
1.1
—
—
—
0
0
8
17
4.86
2.95
1.3
1.1
—
—
—
0
0
7
13
5.54
2.89
1.3
1.2
—
—
—
0
0
6
9
6.83
2.89
4.5
1.2
—
—
—
0
0
10
28
3.71
2.82
1.5
1.2
—
—
—
0
0
13
48
2.83
2.78
2.5
3.8
—
—
—
0
0
5
6
8.51
2.76
2.0
1.0
—
—
—
0
0
7
14
5.14
2.75
1.6
1.2
—
—
—
0
0
7
14
5.14
2.75
1.6
1.2
—
—
—
0
0
6
10
6.15
2.72
1.8
1.2
—
—
—
0
0
57
382
1.70
2.70
6.2
3.9
0.00
0.00
estimate
-0.00
23
107
5
8
6.38
2.38
1.8
1.4
—
—
—
0
0
96
752
1.55
2.34
5.9
3.6
0.00
0.01
estimate
0.50
25
116
184
1706
2.52
2.24
41.8
13.9
82.47
78.37
umol/l
0.42
184
1706
96
758
1.53
2.22
7.8
5.0
0.00
0.00
estimate
-0.00
24
109
77
580
1.54
2.21
6.5
3.7
—
—
—
0
0
116
961
1.52
2.09
2.6
2.7
—
—
—
0
0
5
10
5.10
2.08
1.2
1.8
10.00
12.90
umol/l
—
5
10
9
32
2.90
2.03
1.6
2.0
—
—
—
0
0
9
32
2.90
2.03
2.1
1.1
—
—
—
0
0
44
302
1.59
1.86
1.7
1.7
1488.31
1171.75
nmol/l
0.88
35
229
6
18
3.40
1.76
1.5
1.3
—
—
—
0
0
82
651
1.45
1.73
2.4
2.5
75.25
77.08
nmol/l
0.25
77
580
12
55
2.26
1.71
1.3
1.2
—
—
—
0
0
94
768
1.43
1.69
5.8
3.6
0.00
0.00
estimate
-0.00
24
106
12
56
2.22
1.65
1.3
1.2
—
—
—
0
0
10
42
2.45
1.64
1.3
1.3
—
—
—
0
0
6
21
2.91
1.51
1.0
1.2
—
—
—
0
0
15
82
1.90
1.40
6.9
2.7
0.57
0.64
%
0.36
15
82
135
1200
1.41
1.39
4.1
3.7
14.78
14.92
pmol/l
0.28
122
1086
117
1016
1.38
1.38
3.0
3.0
59.52
49.55
u/l
0.47
112
946
6
23
2.66
1.38
1.0
1.5
—
—
—
0
0
6
23
2.66
1.38
3.0
1.2
186.67
59.32
pmol/l
—
6
23
5
17
2.99
1.36
1.4
1.1
—
—
—
0
0
82
679
1.36
1.28
2.0
1.9
87.74
95.60
pmol/l
0.68
51
343
15
85
1.83
1.27
1.3
1.3
—
—
—
0
0
15
85
1.83
1.27
6.9
2.8
1.21
1.23
%
0.03
15
85
5
19
2.67
1.22
1.0
1.7
3.16
197.65
u/ml
—
5
19
186
1788
1.98
1.20
51.1
17.5
244.94
245.17
e9/l
0.01
178
1741
186
1788
1.98
1.20
51.9
17.6
37.34
40.60
%
8.08
174
1658
186
1789
1.96
1.20
51.1
17.5
4.21
4.54
e12/l
11.08
178
1735
5
22
2.31
1.04
2.4
1.9
—
—
—
0
0
16
99
1.67
1.03
1.2
1.2
945.06
264.43
u/ml
0.37
16
90
10
53
1.93
1.03
1.9
1.6
—
—
—
0
0
6
116
0.50
0.98
1.3
1.8
—
—
—
0
0
143
1532
0.75
0.97
5.2
6.0
38.91
40.40
mmol/mol
1.28
133
1421
21
143
1.53
0.94
2.0
1.9
37.77
29.96
u/l
0.19
13
119
6
31
1.96
0.85
1.2
1.3
—
—
—
0
0
40
318
1.32
0.79
3.5
3.6
25.86
402.25
ng/l
2.11
30
250
157
1639
0.78
0.63
4.0
5.2
2.61
2.69
mmol/l
0.54
143
1513
46
543
0.80
0.63
2.7
3.8
13.52
7.47
mg/mmol
0.35
25
349
9
60
1.52
0.55
1.6
1.8
—
—
—
0
0
6
38
1.60
0.55
1.3
1.7
—
—
—
0
0
9
136
0.65
0.53
1.1
1.8
—
—
—
0
0
26
207
1.30
0.53
7.2
7.3
—
—
—
0
0
39
331
1.22
0.48
1.5
1.7
449.21
430.29
pmol/l
0.22
29
271
11
149
0.72
0.42
1.1
2.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
7.49
—
0
11
155
1603
0.84
0.41
3.7
4.7
4.43
4.58
mmol/l
1.04
143
1481
154
1593
0.84
0.40
3.7
4.6
1.36
1.46
mmol/l
2.20
140
1468
68
618
1.15
0.39
4.4
3.7
4.21
1.94
ug/l
0.67
62
548
0
19
0.00
0.39
0.0
1.3
—
—
—
0
0
154
1484
1.18
0.38
5.1
4.4
1.85
1.92
mu/l
0.24
142
1352
23
189
1.25
0.38
1.6
1.4
—
—
—
0
0
154
1588
0.85
0.34
4.3
4.6
5.84
5.99
mmol/l
0.95
138
1440
39
347
1.16
0.30
2.5
2.4
0.99
0.72
ug/l
0.47
27
223
24
278
0.84
0.28
1.1
1.3
13.98
34.47
iu/ml
—
5
80
30
267
1.15
0.23
1.3
1.5
—
—
—
0
0
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
5
43
1.17
0.21
1.6
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
3.0
—
13.67
—
0
13
38
347
1.12
0.20
1.2
1.3
1.98
1.09
u/ml
0.45
15
91
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
24
215
1.13
0.17
4.1
4.4
30.95
32.25
%
0.34
19
138
50
487
1.04
0.04
4.0
3.7
20.91
24.39
%
0.97
22
223
17
161
1.06
0.03
1.9
2.7
5.55
6.92
ug/l
0.23
17
142
153
1529
1.00
0.00
3.4
4.2
1.23
1.28
mmol/l
0.54
141
1401
14
137
1.02
0.00
1.6
3.3
143.14
168.90
ng/l
0.16
14
123
26
262
0.99
0.00
1.2
1.3
30.40
10.41
u/ml
—
5
108
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
7.28
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
7.53
—
0
6
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
17.97
—
0
6
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
8
81
0.99
-0.00
1.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_BONE_CARTILAGE_NAS – Malignant neoplasm of bone and articular cartilage of other and unspecified sites
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).